By admin 
Pharma major Panacea Biotec Pharma Limited is set to acquire nutraceutical brand Power Gummies, according to sources aware of the matter. “The transaction is close to being finalized. Panacea Biotec will acquire the entire stake in Power Gummies, including its patents and trademarks,” said one of the sources. The person requested anonymity.
Power Gummies has raised around Rs 76.6 crore ($9 million), including its $6 million Series A funding led by 9Unicorns (now 100Unicorns). The company also raised Rs 10 crore from Jaipuria Family Office and Quadrant in December last year. For the fiscal year ending in March 2024, Power Gummies reported an operating revenue of Rs 17.4 crore against Rs 21.1 crore in FY23. Its net loss widened to Rs 21 crore from Rs 19.1 crore year-on-year. Panacea Biotec, which offloaded its domestic formulations business to Mankind Pharma in 2022 for about Rs 1,900 crore, is now eyeing growth through acquisitions. Its planned takeover of Power Gummies signals a pivot towards the nutraceutical and lifestyle wellness space, expanding beyond its traditional pharma and vaccine portfolio.
About Power Gummies
The founder of Power Gummies is Divij Bajaj, a data scientist and entrepreneur who launched the nutraceutical brand in 2018 to provide enjoyable, chewable vitamin supplements. Bajaj’s vision was to blend healthtech with consumer-friendly innovation, offering alternatives to traditional pills through his company, Aesthetic Nutrition Private Limited. Power Gummies has positioned itself as a health and wellness brand tailored for modern lifestyles. It claims to offer unique formulations validated by WHO-standard clinical trials, backed by strong R&D and sustainable manufacturing practices. The company’s portfolio spans across categories including hair, skin, sleep, immunity, stamina, and gut health.